Meeting Provides Opportunity for Partnership with Contact Lens Educators and
Review of Advancements in Myopia Management
SAN RAMON, Calif., January 22, 2020 — To educate contact lens faculty—and to collaborate on how to best support them, their students, residents and schools—CooperVision will sponsor the annual Educator’s Meeting for the fourth consecutive year, on Thursday, January 23 in Las Vegas, immediately prior to the Global Specialty Lens Symposium (GSLS).
All schools and colleges of optometry across North America will have the opportunity to learn more about the latest trends and advancements in specialty contact lens technology, including CooperVision MiSight® 1 day—the first and only contact lens FDA-approved for slowing the progression of myopia when initially prescribed for children 8-12 years old*1, which is the cornerstone of CooperVision’s recently-announced Brilliant FuturesTM Myopia Management Program.
“As we look to the future of optometry, it is through our partnership with educators that we can help prepare tomorrow’s eye care professionals for what is to come,” said Michele Andrews, OD, Senior Director of Professional and Academic Affairs, North America, CooperVision. “The exchange of updates and ideas is mutually beneficial, as the Educator’s Meeting enables CooperVision to more deeply understand unmet needs of the faculty—as well as the questions and issues that they face—to inform the development of the tools they need to help their students become better optometrists.”
The half-day meeting will feature several sessions related to MiSight 1 day, including an overview of the clinical study results, lens design, and clinical protocol from Debbie Jones, FCOptom, FAAO, as well as a panel discussion featuring eye care professionals with experience fitting patients in the lens in Canada. Panelists include Tina Goodhew, OD and Jeff Goodhew, OD, as well as Sheila Morrison, OD, MS, FSLS. Experts from two CooperVision Specialty EyeCare businesses—Paragon Vision Sciences and Blanchard Contact Lenses—will also provide updates to attendees.
Following the Educator’s Meeting, the Global Specialty Lens Symposium continues through Saturday, January 25.
# # #
MiSight® 1 day contact lenses are currently approved for sale in the United States, Canada, the United Kingdom, France, Spain, Portugal, Netherlands, Belgium, Germany, Austria, Switzerland, the Nordic Region, Italy, Singapore, Malaysia, Hong Kong, Australia and New Zealand.
*Indications for use: MiSight® 1 day (omafilcon A) soft (hydrophilic) contact lenses for daily wear are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75 to -4.00 diopters (spherical equivalent) with ≤ 0.75 diopters of astigmatism. The lens is to be discarded after each removal.
1 Compared to a single vision 1 day lens over a 3 year period Chamberlain P et al A 3-year Randomized Clinical Trial of MiSight Lenses for Myopia Control. Optom Vis Sci 2019; 96:556-567.
CooperVision, a division of CooperCompanies (NYSE:COO), is one of the world’s leading manufacturers of soft contact lenses. The Company produces a full array of daily disposable, two-week and monthly contact lenses, all featuring advanced materials and optics. CooperVision has a strong heritage of solving the toughest vision challenges such as astigmatism, presbyopia and childhood myopia; and offers the most complete collection of spherical, toric and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, creating real advantages for customers and wearers. For more information, visit www.coopervision.com.
CooperCompanies ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, Calif., Cooper has a workforce of more than 12,000 with products sold in over 100 countries. For more information, please visit www.coopercos.com.
McDougall Communications for CooperVision, Inc.
email@example.com or 585-434-2149